Alexander Colevas
Publication Details
-
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Cancer Biol Ther. 2007; (4): 490-3
Ixabepilone (BMS-247550) is a semi-synthetic analog of epothilone B that has been characterized as a microtubule stabilizing agent with a mechanism of action distinct from taxanes. Suggestion of activity in renal cell carcinoma (RCC) has been seen in early clinical studies.
Help
Trial Administration